European Journal of Pediatrics

, Volume 152, Issue 10, pp 818–821

Failure of calcitriol treatment in a patient with malignant osteopetrosis

Authors

  • E. M. van Lie Peters
    • Department of PaediatricsAcademic Hospital Leyden
  • D. C. Aronson
    • Department of Paediatric SurgeryAcademic Medical Centre
  • V. Everts
    • Experimental Oral Biology Group, Laboratory of Cell Biology and HistologyUniversity of Amsterdam
  • L. J. Dooren
    • Department of PaediatricsAcademic Hospital Leyden
Medical Genetics

DOI: 10.1007/BF02073378

Cite this article as:
van Lie Peters, E.M., Aronson, D.C., Everts, V. et al. Eur J Pediatr (1993) 152: 818. doi:10.1007/BF02073378

Abstract

In an attempt to stimulate bone resportion, a 10-week-old infant with malignant infantile osteopetrosis was treated with high doses of calcitriol, a potent bone resorption stimulatory agent, combined with a low calcium diet to prevent hypercalcaemia. Although calcitriol administration was initiated at this very young age, our patient did not show any clinical, radiological, or histological improvement. Despite reports of positive results of this treatment in the literature, our patient did not reveal any signs of bone resorption. She eventually died from the complications of osteopetrosis at the age of 6 months after 88 days of therapy.

Key words

Malignant infantile osteopetrosisCalcitriol
Download to read the full article text

Copyright information

© Springer-Verlag 1993